Sorrento Therapeutics, Inc. Uncategorized Contracts & Agreements

40 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Manufacturing Technology Transfer Agreement, dated November 2, 2023, between Yuhan Corporation and Sorrento Therapeutics, Inc
Sorrento Therapeutics, Inc.
Biotechnology
NY
2023
Amendment No. 1 to Sponsor Support Agreement, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Scilex Holding Company and each of the Persons set forth on...
Sorrento Therapeutics, Inc.
Biotechnology
2022
Stockholder Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc. and Vickers Vantage Corp. I
Sorrento Therapeutics, Inc.
Biotechnology
DE
2022
Offer Letter, dated April 27, 2022, between Scilex Holding Company and Elizabeth A. Czerepak
Sorrento Therapeutics, Inc.
Biotechnology
2022
Offer Letter, dated April 27, 2022, between Sorrento Therapeutics, Inc. and Elizabeth A. Czerepak
Sorrento Therapeutics, Inc.
Biotechnology
2022
Company Stockholder Support Agreement, dated as of March 17, 2022, by and among Sorrento Therapeutics, Inc., Scilex Holding Company and Vickers Vantage Corp. I
Sorrento Therapeutics, Inc.
Biotechnology
2022
Sponsor Support Agreement, dated as of March 17, 2022, by and among Vickers Vantage Corp. I and each of the Persons set forth on Schedule I attached thereto
Sorrento Therapeutics, Inc.
Biotechnology
DE
2022
Description of Securities of Sorrento Therapeutics, Inc
Sorrento Therapeutics, Inc.
Biotechnology
2022
Contract, dated August 15, 2018, by and between Hangzhou ACEA Pharmaceutical Research Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd. (translated into English from its original text...
Sorrento Therapeutics, Inc.
Biotechnology
2021
Earn-Out Agreement, dated June 1, 2021, by and between Sorrento Therapeutics, Inc. and Fortis Advisors LLC
Sorrento Therapeutics, Inc.
Biotechnology
DE
2021
Description of Securities of Sorrento Therapeutics, Inc
Sorrento Therapeutics, Inc.
Biotechnology
2021
Description of Securities of Sorrento Therapeutics, Inc
Sorrento Therapeutics, Inc.
Biotechnology
2020
Collateral Agreement, dated as of September 7, 2018, by and between Scilex Pharmaceuticals Inc. and U.S. Bank National Association, as trustee and collateral agent
Sorrento Therapeutics, Inc.
Biotechnology
DE
2018
Offer Letter, dated March 15, 2018, by and between Sorrento Therapeutics, Inc. and Jiong Shao
Sorrento Therapeutics, Inc.
Biotechnology
2018
[Signature Page Follows]
Sorrento Therapeutics, Inc.
Biotechnology
CA
2016
OPTION AGREEMENT
Sorrento Therapeutics, Inc.
Biotechnology
CA
2016
SORRENTO THERAPEUTICS, INC. and PHILADELPHIA STOCK TRANSFER, INC., Rights Agent Amended and Restated Rights Agreement Dated asof December 21, 2015 TABLE OF CONTENTS
Sorrento Therapeutics, Inc.
Biotechnology
DE
2015
STOCKHOLDERS AGREEMENT dated as of December23, 2014 by and among CONKWEST, INC., SORRENTO THERAPEUTICS, INC., CAMBRIDGE EQUITIES, LP and THE PERSONS LISTEDON SCHEDULE A HERETO...
Sorrento Therapeutics, Inc.
Biotechnology
CA
2014
SORRENTO THERAPEUTICS, INC. and PHILADELPHIA STOCK TRANSFER, INC., Rights Agent Amended and Restated Rights Agreement Dated asof December 22, 2014 1 TABLE OF CONTENTS
Sorrento Therapeutics, Inc.
Biotechnology
DE
2014
AMENDMENT #7
Sorrento Therapeutics, Inc.
Biotechnology
2014
SORRENTO THERAPEUTICS, INC. and COMPUTERSHARE TRUST COMPANY, N.A., Rights Agent Rights Agreement Dated as of November 7, 2013 TABLE OF CONTENTS
Sorrento Therapeutics, Inc.
Biotechnology
DE
2013
EXCLUSIVE OPTION AGREEMENT by and between B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., an Israeli Company and SORRENTO THERAPEUTICS, INC., a Delaware (US) corporation EXCLUSIVE...
Sorrento Therapeutics, Inc.
Biotechnology
NY
2013
OPTION AGREEMENT Dated as of March 7, 2013 by and between SORRENTO THERAPEUTICS, INC. and IGDRASOL, INC. TABLE CONTENTS
Sorrento Therapeutics, Inc.
Biotechnology
CA
2013
AMENDMENT #6
Sorrento Therapeutics, Inc.
Biotechnology
2012
AMENDMENT #5
Sorrento Therapeutics, Inc.
Biotechnology
2012
AMENDMENT #4
Sorrento Therapeutics, Inc.
Biotechnology
2012
AMENDMENT #3
Sorrento Therapeutics, Inc.
Biotechnology
2012
AMENDMENT #4
Sorrento Therapeutics, Inc.
Biotechnology
2011
AMENDMENT #3
Sorrento Therapeutics, Inc.
Biotechnology
2011
SORRENTO THERAPEUTICS, INC. 2009 EQUITY INCENTIVEPLAN Approved by the Board of Directors: February 5, 2009
Sorrento Therapeutics, Inc.
Biotechnology
DE
2010
AMENDMENT #2
Sorrento Therapeutics, Inc.
Biotechnology
2010
SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT.WEST, SUITE B SAN DIEGO, CA 92121, USA
Sorrento Therapeutics, Inc.
Biotechnology
2010
AMENDMENT #2
Sorrento Therapeutics, Inc.
Biotechnology
2009
SORRENTO THERAPEUTICS, INC. INDEMNITY AGREEMENT
Sorrento Therapeutics, Inc.
Biotechnology
DE
2009
SORRENTO THERAPEUTICS, INC. TRANSFER FEE $25.00
Sorrento Therapeutics, Inc.
Biotechnology
2009
PLAN OF CONVERSION OF QuikByte Software, Inc., aColorado corporation, INTO QuikByte Software, Inc., a Delaware corporation
Sorrento Therapeutics, Inc.
Biotechnology
CO
2009
QuikByte Software, Inc. 4400 Biscayne Boulevard, Suite 950 Miami, Florida 33137
Sorrento Therapeutics, Inc.
Biotechnology
2009
QuikByte Software, Inc. 4400 Biscayne Boulevard, Suite 950 Miami, Florida 33137
Sorrento Therapeutics, Inc.
Biotechnology
2009
LOCK-UP AGREEMENT
Sorrento Therapeutics, Inc.
Biotechnology
2009
AGREEMENT
Sorrento Therapeutics, Inc.
Biotechnology
2007